Your patients deserve the best allergy care available. Wyndly’s treatment method is guided by experts from leading universities and backed by thousands of studies.

Moreover, our modern practice gives your patients the best care- not just what insurance companies cover. Our sublingual treatment plans are cheaper, less painful, and more convenient than traditional allergy shots. Our providers give your patients VIP level care with text, video, email and phone access 24-7.

We believe patients should be tested in the way that makes the most sense for them. If a patient has had an allergy skin test, our physician will review those results with them.  

Some patients are scared of the multiple needles required for skin prick testing, and we think they should still be able to fix their allergies. 

For these patients, we offer an easy home-allergy test kit. We work with a lab that has been CLIA certified and this newer technology has been shown to have similar accuracy to skin prick testing.

Ultimately, our team believes in following the latest clinical evidence.  As stated in the International Consensus Statement on Allergy and Rhinology for 2018, ‘neither skin or sIgE [blood] testing can definitely predict the severity of a patients sensitivity to an aeroallergen.”  So our physicians don't just treat test results, we focus on treating the whole patient and their history.

Both skin testing and blood testing allergy results should always be interpreted within the context of a patients allergy history.

Because skin testing can vary depending on the clinician or staff administering and interpreting an allergy test, our physicians reserve the right to repeat allergy testing if there are any questions about prior test accuracy or reliability.

During the Covid-19 pandemic, Dr. Manan Shah, Chair Elect of the YPS of the AAO-HNS and President of the Colorado ENT Society, wanted to ensure his patients continued to have access to their allergy care. Through telemedicine, he realized his patients could have increased access, and increased convenience. 

By partnering with leading physicians at Stanford, Case Western, and physicians around the country, Wyndly was created to ensure every patient has access to convenient, evidence based allergy care.

Wyndly treats the 40 million Americans who are suffering with allergies.  We focus on environmental allergies which affect your patients ability to sleep, breathe, grow and enjoy the outdoors or their pets. 

Sublingual immunotherapy is a good solution for a few types of people:

- Someone who is allergic to multiple things

- Someone who can’t control their symptoms with over-the-counter medications

- Anyone who has had a bad reaction to an allergy medication

- Children ages 5 and older whose parents are hoping to try and prevent them from getting asthma later in life

- Anyone who doesn’t want to be stuck on allergy medication forever

- Someone who has both allergies and asthma and wants to treat them

Wyndly’s physicians create personalized sublingual immunotherapy treatment plans that help patients fix their allergies for long-term relief.

Sublingual immunotherapy works by exposing the patient’s body to small doses of what they’re allergic to on a daily basis for an extended period of time. Over time, the immune system changes and the patient becomes desensitized - so they live better.

Two separate evidence based systematic reviews from 2003 and 2010  have shown sublingual immunotherapy to be safe and effective for treating environmental allergies. This data resulted in the FDA approving SLIT therapy in the United States in tablet form.

Sublingual immunotherapy is considered a safer alternative to allergy shots due to the significantly lower risk of anaphylaxis. This is why sublingual immunotherapy is prescribed for use at home, whereas shots require a physician office visit. 

The current literature suggests allergy drops are significantly safer than allergy shots, this is why they are typically prescribed at home. The risk of anaphylaxis with sublingual immunotherapy is described in the literature as 1 in 100 million. 

Out of 49 clinical trials utilized in the Cochrane review studies, there were no severe allergy reactions or cases of anaphylaxis.

Yes. Comparison studies have shown that both methods are effective at providing long term allergy relief for patients. A 2016 review of the literature in the Journal of Allergy and Clinical Immunology, the journal of the American Academy of Allergy, Asthma & Immunology, found that the evidence supports both as being effective, and recommends the choice between sublingual immunotherapy or allergy shots be be based on patient preference.

Because the data shows both to be equivalent, sublingual is considered an equally effective alternative to allergy shots. 

Furthermore, in the cochrane review in 2010, the two studies that compared injection immunotherapy with SLIT directly reported similar improvements in symptoms and medication requirements for both routes of administration.

Sublingual immunotherapy is a more recent innovation in allergy care than allergy shots. While the therapy has been around since the 1980’s, its uptake in the US has been mostly since the 2010’s. Allergy drops, a type of sublingual immunotherapy, have been available in major academic hospitals for years however.